Since more than 30 years, we have reported that experimental atherosclerosis similar to that of human beings was produced in monkeys by Vitamin B
6 deprived diet. However, the mechanism of forming atherosclerotic lesion in Vitamin B
6 deficiency was not obvious. On the other hand, the endothelial and smooth muscle cell were suspected to play an important role in the initiation and its development of atherosclerosis. Also, some investigators began to be interested in the role of thromboxane A
2 and prostacyclin in the formation of atherosclerotic lesion. Therefore, by using Vitamin B
6 antagonists, we examined the effect of Vitamin B
6 deficiency on prostacyclin production by the cultured endothelial cells from fetal bovine aorta. We assayed the prostacyclin production by measuring the 6-keto-PGF
1α, a stable metabolite of prostacyclin.
On the other hand, it is reported that the patients with homocystinuria, who lack the activity of cystathionine synthetase which needs Vitamin B
6 as a cofactor, have the tendency to suffer from atherosclerosis in their early life. So we also studied the effect of homocysteine on prostacyclin production. To evaluate the degree of cell damage, we also measured the level of LDH in the culture media.
As Vitamin B
6 antagonists, we used deoxypyridoxine HCl and Isoniazid. No difference was detected between control and Vitamin B
6 antagonists added group in LDH level. When dl-homocysteine at various doses as follows was added, LDH levels were 1.1±0.4, 16.0±2.2, 115.0±7.4, 201.2±3.2 (Wroblewski unit) at 0mM (control), 2mM, 5mM, 10mM, respectively.
6-keto-PGF
1α production was expressed as percentage to control. When isoniazid was added, the results were 125.0±2.8% or 146.4±55.0% at concentration of 0.1mM or 1mM, respectively. When deoxypyridoxine HCl was added, the results were 132.4% or 106.7% at concentration of 2.5mM or 5mM, respectively. When dl-homocysteine was added, the results were 58.4±22.8% or 41.6±9.7% at concentration 5mM or 10mM, respectively.
We already reported that homocysteine had endothelial cell detaching potential and increased the number of circulating endothelial cells when it was injected into experimental animals. Jones reported homocysteine inhibited prostacyclin production by rat aortic ring. In this study, homocysteine gave injury to endothelial cells and suppressed prostacyclin production in a dose dependent manner. Therefore, it was suggested from above results that the homocysteine might contribute to the cell damaging. However, because it was supposed that the atherosclerosis might be caused by the impairment of multiple factors, for example, endothelial cells, smooth muscle cells, platelets, coagulants and their interactions in vivo, further investigations would be necessary.
抄録全体を表示